CERES NANOSCIENCES — Department of Defense SBIR Phase I: We have developed a novel nanotechnology that overcomes major roadblocks that limit the ab

Description

We have developed a novel nanotechnology that overcomes major roadblocks that limit the ability to collect, process, analyze and store biological samples at ambient temperatures over extended periods of time. Ceres will fabricate and demonstrate Nanotrap-enabled dried biofluid sample collection paper technology suitable for a range of biofluids (whole blood, plasma, saliva, urine, food matrices) and analyte classes (proteins, peptides, metabolites, toxins, nucleic acids). The proposed technology is specifically designed for scientific research, monitoring of health and exposure and evaluation of countermeasure efficacy where standard sample collection, preservation techniques and equipment are impractical, inefficient and unreliable. The results of this Phase I effort will extend our patented Nanotrap sample preparation technology for sample collection applications for use in DoD point-of-need sample collection as well as routine clinical and personalized medicine applications.